Aimovig (erenumab-aooe) - Amgen
Efficacy and Safety of Erenumab in the Preventive and Therapeutic Treatment of Patients Suffering From Migraine. (PubMed, Cureus) - Sep 30, 2026 - "These findings suggest that erenumab is effective for migraine prevention and was not associated with a statistically significant increase in adverse or serious adverse events compared with placebo in the included trials. Overall, the available evidence supports erenumab as an effective preventive treatment for patients with episodic or chronic migraine." 
Journal • Review • CNS Disorders • Migraine • Pain
http://www.ncbi.nlm.nih.gov/pubmed/42808046
 
Aarav Patel; Harshini S Rathod; Pankhuri Saxena; Siddharth Panchal; Vishwa Parker; Yatri Patel
 
Sep 30, 2026
 
Prev Next